Ardelyx stocktwits sghkqxs

Ardelyx stocktwits

28.10.2020

Bjorgen36752

Stock Picks, Stock Market Investing | Seeking Alpha Market Data Disclaimer | © 2020 Seeking Alpha Daniel Levran (@DanilaMaster) | Stocktwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

On September 12, 2019, Ardelyx received approval of IBSRELA (tenapanor) for the treatment of irritable bowel syndrome with constipation (IBS-C). To efficiently bring its treatments to market, Ardelyx is pursuing strategic collaborations for IBSRELA for IBS-C and …

Events & Presentations | Ardelyx, Inc. 9 rows

Ardelyx earned a coverage optimism score of -3.8 on InfoTrie's scale. They also gave press coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term.

ARDX on StockCharts.com Ardelyx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics to treat cardio-renal, gastrointestinal (GI), and metabolic diseases. The Investor Relations website contains information about Ardelyx, Inc.'s business for stockholders, potential investors, and financial analysts.

Ardelyx, Inc. Biotechnology Fremont, CA 3,550 followers Passionately committed to bettering the lives of patients with kidney and cardiovascular diseases.

Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California. StockTwits Facebook Twitter Real Estate Sign Post Installation SwingTradeBot Australia (ASX) SwingTradeBot Canada (TSX & TSXV) SwingTradeBot London / UK (LSE & AIM) SwingTradeBot OTCBB (USA) 5 Wall Street analysts have issued ratings and price targets for Ardelyx in the last 12 months. Their average twelve-month price target is $12.00, suggesting that the stock has a possible upside of 73.41%. The high price target for ARDX is $15.00 and the low price target for ARDX is $9.00. FREMONT, Calif. "We are pleased to welcome Onaiza to our board of directors," said Mike Raab, president and chief executive officer of Ardelyx (ARDX). "With three successful Phase 3 trials for their lead therapeutic, tenapanor, this is an extremely exciting time for Ardelyx," said Ms. Cadoret-Mainer. Real-time trade and investing ideas on Ardelyx ARDX from the largest community of traders and investors. ARDX Stock Summary. Ardelyx Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.38% of US listed stocks. Technical Analysis for ARDX - Ardelyx, Inc. Quote; Chart; Signals; Profile; Buy or See more ARDX news ARDX Ideas on StockTwits · ARDX Tweets on Twitter. Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Settings. Click the Settings icon to access different options for your chart.. DISPLAY Tab. Bar Type: For each Bar Type, you may customize the color and thickness of the bars. OHLC Bars are drawn to show the open-high-low-close. A vertical line is drawn between the highest and lowest price. The horizontal dash extending to the left of the bar represents the open, and the horizontal dash

Nov 1, 2017 Raphael Ornaf (retired), Hernan Fuentes of Ardelyx, Terence Lo from SiteJot Skype Slashdot SMS StockTwits Svejo Symbaloo Bookmarks